CCM

Camber Capital Management Portfolio holdings

AUM $718M
1-Year Est. Return 4.23%
This Quarter Est. Return
1 Year Est. Return
-4.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$718M
AUM Growth
-$885M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$43.6M
2
+$39.6M
3
+$31.2M
4
APLS icon
Apellis Pharmaceuticals
APLS
+$14.7M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.5M

Top Sells

1
+$114M
2
+$104M
3
+$87.8M
4
CVS icon
CVS Health
CVS
+$82.8M
5
PTCT icon
PTC Therapeutics
PTCT
+$76.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
26
Structure Therapeutics
GPCR
$2.13B
– –
-300,000
GSK icon
27
GSK
GSK
$95.9B
– –
0
IONS icon
28
Ionis Pharmaceuticals
IONS
$13.2B
– –
-725,000
MLTX icon
29
MoonLake Immunotherapeutics
MLTX
$952M
– –
-441,000
PTCT icon
30
PTC Therapeutics
PTCT
$6.5B
– –
-1,500,000
QGEN icon
31
Qiagen
QGEN
$10.3B
– –
-1,400,000
SPY icon
32
SPDR S&P 500 ETF Trust
SPY
$699B
– –
0
SRPT icon
33
Sarepta Therapeutics
SRPT
$2.11B
– –
-800,000
TXG icon
34
10x Genomics
TXG
$2.32B
– –
-1,000,000
XBI icon
35
State Street SPDR S&P Biotech ETF
XBI
$7.98B
– –
0
1
2